Abstract
There is growing enthusiasm regarding left atrial appendage (LAA) occlusion (LAAO) in the prevention of atrial fibrillation- (AF-) related stroke. A meta-analysis comparing 5-year outcomes of the Watchman (Boston Scientific) LAAO device versus warfarin found that LAAO was comparable in stroke prevention and had less risk of bleeding, intracranial hemorrhage (ICH), and mortality.1 Additionally, the recent Left Atrial Appendage Occlusion Study III trial added enthusiasm about the stroke reduction capacity of LAAO.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
